170 related articles for article (PubMed ID: 22469131)
1. Inhibition of phosphodiestrase 9 induces cGMP accumulation and apoptosis in human breast cancer cell lines, MCF-7 and MDA-MB-468.
Saravani R; Karami-Tehrani F; Hashemi M; Aghaei M; Edalat R
Cell Prolif; 2012 Jun; 45(3):199-206. PubMed ID: 22469131
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide-cyclic GMP pathway in mice.
da Silva FH; Pereira MN; Franco-Penteado CF; De Nucci G; Antunes E; Claudino MA
Int J Impot Res; 2013; 25(2):69-73. PubMed ID: 23034509
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line.
Wunder F; Tersteegen A; Rebmann A; Erb C; Fahrig T; Hendrix M
Mol Pharmacol; 2005 Dec; 68(6):1775-81. PubMed ID: 16150925
[TBL] [Abstract][Full Text] [Related]
4. Gastrodin promotes hippocampal neurogenesis via PDE9-cGMP-PKG pathway in mice following cerebral ischemia.
Xiao H; Jiang Q; Qiu H; Wu K; Ma X; Yang J; Cheng O
Neurochem Int; 2021 Nov; 150():105171. PubMed ID: 34419525
[TBL] [Abstract][Full Text] [Related]
5. PDE9 inhibition promotes proliferation of neural stem cells via cGMP-PKG pathway following oxygen-glucose deprivation/reoxygenation injury in vitro.
Huan X; Oumei C; Hongmei Q; Junxia Y; Xiaojiao M; Qingsong J
Neurochem Int; 2020 Feb; 133():104630. PubMed ID: 31821840
[TBL] [Abstract][Full Text] [Related]
6. C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.
Wang PX; Li ZM; Cai SD; Li JY; He P; Huang Y; Feng GS; Luo HB; Chen SR; Liu PQ
Acta Pharmacol Sin; 2017 Sep; 38(9):1257-1268. PubMed ID: 28649129
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by type Iβ protein kinase G in the human breast cancer cell lines MCF-7 and MDA-MB-468.
Fallahian F; Karami-Tehrani F; Salami S
Cell Biochem Funct; 2012 Apr; 30(3):183-90. PubMed ID: 22095901
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.
Fallahian F; Karami-Tehrani F; Salami S; Aghaei M
FEBS J; 2011 Sep; 278(18):3360-9. PubMed ID: 21777390
[TBL] [Abstract][Full Text] [Related]
9. Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium.
Hambleton R; Krall J; Tikishvili E; Honeggar M; Ahmad F; Manganiello VC; Movsesian MA
J Biol Chem; 2005 Nov; 280(47):39168-74. PubMed ID: 16172121
[TBL] [Abstract][Full Text] [Related]
10. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
11. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
12. Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains.
Reyes-Irisarri E; Markerink-Van Ittersum M; Mengod G; de Vente J
Eur J Neurosci; 2007 Jun; 25(11):3332-8. PubMed ID: 17553001
[TBL] [Abstract][Full Text] [Related]
13. The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice.
Liddie S; Anderson KL; Paz A; Itzhak Y
J Psychopharmacol; 2012 Oct; 26(10):1375-82. PubMed ID: 22596207
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.
Diederen RM; La Heij EC; Markerink-van Ittersum M; Kijlstra A; Hendrikse F; de Vente J
Br J Ophthalmol; 2007 Mar; 91(3):379-84. PubMed ID: 16943225
[TBL] [Abstract][Full Text] [Related]
15. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice.
Almeida CB; Scheiermann C; Jang JE; Prophete C; Costa FF; Conran N; Frenette PS
Blood; 2012 Oct; 120(14):2879-88. PubMed ID: 22833547
[TBL] [Abstract][Full Text] [Related]
17. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
[TBL] [Abstract][Full Text] [Related]
18. Hydroalcoholic Extract of Levisticum officinale Increases cGMP Signaling Pathway by Down-Regulating PDE5 Expression and Induction of Apoptosis in MCF-7 and MDA-MB-468 Breast Cancer Cell Lines.
Lotfian Sargazi M; Saravani R; Shahraki A
Iran Biomed J; 2019 Jul; 23(4):280-6. PubMed ID: 30388886
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
20. Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease.
Kokkonen-Simon KM; Saberi A; Nakamura T; Ranek MJ; Zhu G; Bedja D; Kuhn M; Halushka MK; Lee DI; Kass DA
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
